Valneva SE


Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. They focus on vaccines for diseases such as chikungunya, Lyme disease, Shigella, and Zika, and have leveraged their expertise to commercialize three vaccines and advance a broad range of vaccine candidates. The company actively participates in shareholder meetings, provides extensive documentation, and engages in corporate governance and financial reporting.

Industries

biotechnology
health-care
medical
therapeutics

Nr. of Employees

large (251-1000)

Valneva SE

Saint-herblain, Pays de la Loire, France, Europe


Products

Chikungunya Vaccine (IXCHIQ®)

A vaccine developed by Valneva for the prevention of chikungunya, an infectious disease transmitted by mosquitoes.

IXCHIQ® (Chikungunya Vaccine)

A vaccine developed by Valneva for the prevention of chikungunya, an infectious disease transmitted by mosquitoes.

Chikungunya Vaccine (IXCHIQ®)

A vaccine developed by Valneva for the prevention of chikungunya, an infectious disease transmitted by mosquitoes.

Chikungunya Vaccine (IXCHIQ®)

A vaccine developed by Valneva for the prevention of chikungunya, an infectious disease transmitted by mosquitoes.

Lyme Disease Vaccine Candidate

A vaccine candidate in development aimed at preventing Lyme disease, a tick-borne illness.

Lyme Disease Vaccine Candidate

A vaccine candidate in development aimed at preventing Lyme disease, a tick-borne illness.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.